Small Intestinal Bacterial Overgrowth (SIBO)Small Intestinal Bacterial Overgrowth (SIBO)
Prevalenza: Estimated 6-15% in healthy population; up to 80% in IBS patients
Evidence-Ranked Ingredients
| Ingrediente | Grado | Studi | Direzione | |
|---|---|---|---|---|
| Partially Hydrolyzed Guar Gum (PHGG) | C | 2 | Positive | Visualizza → |
| Berberine | C | 2 | Positive | Visualizza → |
About
A condition characterized by excessive bacterial colonization of the small intestine, typically defined as >10^5 CFU/mL on jejunal aspirate or positive lactulose/glucose hydrogen breath test. Causes malabsorption due to bacterial consumption of nutrients and bile acid deconjugation.
Common Symptoms
Risk Factors
- IBS
- Gastric acid suppression (PPIs)
- Structural abnormalities
- Diabetes
- Hypothyroidism
- Prior abdominal surgery
- Chronic opioid use
Frequently Asked Questions
What supplements are studied for Small Intestinal Bacterial Overgrowth (SIBO)?
How is the evidence for Small Intestinal Bacterial Overgrowth (SIBO) supplements graded?
How many studies on Small Intestinal Bacterial Overgrowth (SIBO) supplements have been reviewed?
What are common symptoms of Small Intestinal Bacterial Overgrowth (SIBO)?
Related Conditions
Condizioni che condividono ingredienti studiati
Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.